Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mathey

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Lancet (London, England)|November 2, 1985
Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarctionM Verstraete, W Bleifeld, R W Brower, et al.
European Journal of Heart Failure|October 1, 2009
Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trialVolker Schächinger, Birgit Assmus, Sandra Erbs, et al.
Medecine Et Maladies Infectieuses|September 8, 2018
Multidisciplinary management of patients presenting with Lyme disease suspicionC Jacquet, F Goehringer, E Baux, et al.
The New England Journal of Medicine|September 23, 2006
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarctionVolker Schächinger, Sandra Erbs, Albrecht Elsässer, et al.
Circulation. Heart Failure|December 10, 2009
Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarctionBirgit Assmus, Andreas Rolf, Sandra Erbs, et al.
JACC. Cardiovascular Imaging|March 17, 2012
Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromesUsman Baber, Gregg W Stone, Giora Weisz, et al.
European Heart Journal|November 14, 2006
Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trialVolker Schächinger, Sandra Erbs, Albrecht Elsässer, et al.
Journal of the American College of Cardiology|January 20, 2010
Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registryKrischan D Sjauw, Thomas Konorza, Raimund Erbel, et al.
European Heart Journal|February 27, 2014
Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survivalBirgit Assmus, David M Leistner, Volker Schächinger, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Lancet (London, England)|November 2, 1985
Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarctionM Verstraete, W Bleifeld, R W Brower, et al.
European Journal of Heart Failure|October 1, 2009
Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trialVolker Schächinger, Birgit Assmus, Sandra Erbs, et al.
Medecine Et Maladies Infectieuses|September 8, 2018
Multidisciplinary management of patients presenting with Lyme disease suspicionC Jacquet, F Goehringer, E Baux, et al.
The New England Journal of Medicine|September 23, 2006
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarctionVolker Schächinger, Sandra Erbs, Albrecht Elsässer, et al.
Circulation. Heart Failure|December 10, 2009
Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarctionBirgit Assmus, Andreas Rolf, Sandra Erbs, et al.
JACC. Cardiovascular Imaging|March 17, 2012
Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromesUsman Baber, Gregg W Stone, Giora Weisz, et al.
European Heart Journal|November 14, 2006
Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trialVolker Schächinger, Sandra Erbs, Albrecht Elsässer, et al.
Journal of the American College of Cardiology|January 20, 2010
Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registryKrischan D Sjauw, Thomas Konorza, Raimund Erbel, et al.
European Heart Journal|February 27, 2014
Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survivalBirgit Assmus, David M Leistner, Volker Schächinger, et al.
Pageof 9